Category: Uncategorized

Why Wound Care Claims Keep Getting Denied (And What Actually Fixes It)

Posted on by Reviora Healthcare LLC in Uncategorized

Reviora Healthcare LLC | Guaranteed Revenue Partner

Every denied wound care claim is a bill you already paid — staff time, supplies, clinician hours — with no revenue attached to it. Rework it, and you’re paying twice: once to deliver the care, once to fight for payment on care you already delivered. For a specialty running on thin margins and expensive biologics, that math adds up fast.

Why is wound care coding so denial-prone?

Because almost nothing about it is standardized. Debridement codes are depth-dependent — CPT 11042, 11043, and 11044 depend on the deepest tissue layer removed, not how the wound looks on the surface. Diabetic ulcers typically require dual ICD-10 codes covering both the wound and its underlying cause. Compression and debridement performed on the same limb can trigger bundling edits. One mismatch between depth documentation and the code billed is enough to generate a denial — and wound care has more of these decision points per claim than almost any other specialty.

Why do so many wound care claims stall on prior authorization?

Because skin substitutes, biologics, and negative pressure wound therapy routinely require it, and prior auth is now a documented drag on care nationally. In the American Medical Association’s 2024 Prior Authorization Physician Survey — 1,000 practicing physicians surveyed in December 2024 — prior authorization is described as a cost-control process requiring advance health-plan approval before treatment qualifies for coverage, and separately, 92% of physicians report care delays tied to prior authorization. Every day a graft or biologic sits in PA review is a day of clinical urgency working against your claim, not for it.

What changed for wound care reimbursement in 2026?

CMS overhauled how skin substitutes get paid, and it took effect January 1, 2026. Under the prior model, each skin substitute product had its own billing code and its own average-sales-price-based payment limit — a system CMS says drove Medicare Part B spending on these products from $252 million in 2019 to over $10 billion in 2024, a nearly 40-fold increase. In the CY 2026 Medicare Physician Fee Schedule Final Rule, CMS finalized a single flat payment rate of approximately $127.28 per square centimeter for most skin substitute products, replacing that per-product ASP pricing. If your billing workflow — or your formulary — still assumes the old per-product logic, every claim built on it is now a denial or audit risk.

Is this really worse than other specialties, or does it just feel that way?

It’s a fair question, and the honest answer is: the industry doesn’t yet publish a wound-care-specific denial rate from a primary source like MGMA or HFMA — most of what circulates is billing-vendor marketing, not benchmarking data. What is documented is the trend line for everyone: MGMA’s DataDive Practice Operations benchmarking put the single-specialty aggregate first-submission denial rate at 8% as of 2023, unchanged from 2019, while more recent MGMA figures cited by HFMA show over half of healthcare organizations now report denial rates exceeding 10%. Wound care sits on top of that baseline with three extra layers most specialties don’t carry at the same time: depth-dependent coding, near-universal prior auth on advanced therapies, and a reimbursement model CMS just rebuilt from the ground up.

How do you actually fix this?

You stop treating wound care like a documentation problem and start treating it like a specialty problem. That means claims scrubbed by people who know the difference between a 15271 and a 15275 before submission, not after denial. It means prior authorizations tracked and chased the same day a biologic is ordered, not the day the claim bounces. And it means a billing partner who rebuilt their coding logic around the CMS 2026 rate before January 1 — not the week after a wave of denials hit.

That’s the model behind Reviora’s Specialty-Specific RCM approach: Expert-Led Technology — credentialed specialists make the coding and appeals calls, software supports their judgment rather than replacing it. It’s also why our Managed Outcomes Agreement exists: a written performance agreement with a built-in accountability mechanism if results slip for two consecutive months, so “trust us” isn’t the whole pitch.

If your wound care claims are aging out faster than they used to, don’t wait for Q1 close to find out why. Book a 30-minute consultation and we’ll walk through your denial patterns together — no obligation, no sales pitch.

FAQ

Why do wound care claims get denied so often? Wound care combines depth-dependent coding, dual-diagnosis requirements for chronic wounds, and near-universal prior authorization on biologics and advanced therapies — more failure points per claim than most other specialties, compounded by a 2026 CMS reimbursement overhaul many practices haven’t fully adapted to yet.

What is the 2026 CMS skin substitute payment rule? Effective January 1, 2026, CMS replaced the old product-specific ASP-based payment model for most skin substitutes with a single flat national rate of about $127.28 per square centimeter, finalized in the CY 2026 Medicare Physician Fee Schedule Final Rule.

Do wound care claims need prior authorization? Often, yes — particularly for skin substitutes, biologics, and negative pressure wound therapy under commercial payers and some Medicare Advantage plans. Per the AMA’s 2024 Prior Authorization Physician Survey, most physicians report the process delays patient care.

How can I reduce wound care claim denials? Focus on pre-submission coding accuracy (especially debridement depth and dual ICD-10 pairing), get prior authorizations moving the day treatment is ordered, and confirm your formulary and billing logic reflect the 2026 CMS flat-rate skin substitute policy.

Reference

5 Places Your Practice May Be Losing Revenue

Posted on by Reviora Healthcare LLC in Uncategorized

Reviora Healthcare LLC | Guaranteed Revenue Partner

Your P&L can look fine on the surface and your practice can still be bleeding five or six figures a year — quietly, in places nobody reviews on a Tuesday afternoon. Revenue leakage rarely shows up as one dramatic loss. It shows up as a dozen small ones: a denied claim nobody re-worked, a payer that took 45 days too long, a copay nobody asked for. By the time it’s visible on a financial statement, it’s already gone.

Here are five places specialty practices lose money most often — and what the data says about each one.

Are claims getting denied before they ever reach the payer?

Denials are the most visible leak, and they’re getting worse, not better. A March 2024 MGMA Stat poll found that 60% of medical group leaders reported an increase in their practices’ claim denial rates compared to the same period the year before. MGMA’s own DataDive Practice Operations data set put the single-specialty aggregate first-submission denial rate at 8% — a number that has barely moved since 2019.

Every denied claim means rework: a coder or biller has to stop, investigate, correct, and resubmit — work that costs staff time whether or not the claim ever gets paid. The practices bucking the trend aren’t working denials harder; they’re preventing them earlier, at intake and coding, before the claim ever leaves the building.

Is your money sitting in AR instead of your bank account?

Days in AR is the clearest signal of how fast your practice actually gets paid — and most practices don’t like what it tells them. HFMA’s MAP Keys, the industry-standard benchmark used across revenue cycle management, set the target range for net days in AR at 30 to 40 days, with accounts over 90 days ideally kept below 10% of total receivables.

Every extra week a claim sits unworked is a week that money isn’t funding payroll, supplies, or growth. AR that drifts past 60 or 90 days isn’t just slow — it’s a strong predictor that a percentage of it will never be collected at all.

Is prior authorization quietly consuming your staff’s week?

Prior auth isn’t just a clinical headache — it’s a direct revenue cycle cost. The AMA’s most recent Prior Authorization Physician Survey found that 95% of physicians report prior authorization delays access to necessary care, and 88% say it drives higher overall utilization and administrative waste. Separately, CAQH’s 2024 Index found that only 35% of medical prior authorizations are conducted fully electronically — meaning most of that burden still runs through phone calls, faxes, and payer portals.

That’s staff time spent chasing approvals instead of working denials, verifying eligibility, or following up on aged claims — and it’s one of the most under-measured drains on a specialty practice’s revenue cycle.

Is a credentialing delay keeping a provider from billing at all?

This one doesn’t show up as a denial — it shows up as revenue that was never billable in the first place. A November 2025 MGMA Stat poll found that 32% of medical groups reported some form of credentialing backlog: files stalled, CVO delays, or completions slipping into the following quarter.

A provider who isn’t credentialed and enrolled can’t bill in-network, no matter how many patients they see. For specialty practices bringing on new physicians or renewing existing panels, a stalled file is unbillable clinical time — every single day it sits open.

Are you leaving patient balances on the table at check-out?

Point-of-service collection has quietly gotten worse across the industry. MGMA’s single-specialty Practice Operations data showed the percentage of copayments collected at time of service fell to 56% in 2022, down from 89.9% in 2019 — a swing that reflects both rising patient financial responsibility and looser front-desk collection habits.

Every dollar not collected at check-out becomes a statement, then a follow-up call, then — often — a write-off. It’s the cheapest dollar your practice will ever collect, and it’s the one most often skipped.

What this adds up to

None of these five leaks are dramatic on their own. Together, they’re often the difference between a practice that’s merely surviving and one that’s actually growing. This is exactly why Reviora built the Managed Outcomes Agreement (MOA) — a written performance agreement covering the benchmarks that matter most across denials, AR, and collections — backed by the Benchmark Recovery Protocol, which activates automatically if performance slips for two consecutive months. It’s Expert-Led Technology: our specialists own the outcome, and the technology supports the work rather than replacing the judgment behind it.

If you want a clearer picture of where your own practice is leaking revenue, we’ll walk through it with you — no sales pitch, just a look at your numbers. Book a free 30-minute consultation.

FAQ

What is a good clean claim rate for a medical practice? Clean claim rate measures the percentage of claims that get paid on first submission with no correction needed. Industry benchmarking bodies like MGMA and HFMA treat rates in the mid-90s and above as strong performance; anything meaningfully lower usually points to front-end data or coding issues rather than payer behavior.

How many days should it take to get a medical claim paid? HFMA’s MAP Keys benchmark net days in AR at 30 to 40 days for a healthy revenue cycle, with fewer than 10% of receivables aged past 90 days. Claims routinely sitting past 60 days are a sign of a bottleneck somewhere in the process.

Why do healthcare claims get denied? Denials trace back to a mix of causes — eligibility and registration errors, coding mistakes, missing prior authorization, and timely-filing misses are among the most common. MGMA’s data shows denial rates have been rising industry-wide, which is why prevention at intake matters more than appeals after the fact.

How much revenue does a specialty practice lose to billing and collection gaps? It varies by practice size and specialty, but the leaks compound: denied claims requiring rework, AR aging past collectible windows, uncredentialed providers who can’t bill, and missed point-of-service collections. A revenue cycle assessment is the only reliable way to size the number for your specific practice.

Reference

Orthopedic Prior Authorization Denials Are Rising — Here’s What the Data Shows

Posted on by Reviora Healthcare LLC in Uncategorized

Reviora Healthcare LLC | Guaranteed Revenue Partner

Every denied prior authorization is a surgery pushed back, a patient who may not come back, and revenue your practice already staffed for but can’t collect. If that cycle feels like it’s happening more often this year, it’s not your imagination — it’s showing up in the national data too.

Is Prior Authorization Denial Actually Getting Worse?

Yes, and physicians are saying so directly. Three in four physicians (74%) report that denials have increased over the past five years, per the AMA’s 2025 Prior Authorization Physician Survey. On the request side, 86% of medical group leaders told MGMA in a 2025 MGMA Stat poll that prior authorization requirements themselves have increased in the past year — not just denials, but the volume of procedures now requiring approval before you can even schedule them.

For orthopedic practices specifically, this matters more than most specialties. Surgical and imaging-heavy care — the backbone of orthopedic volume — sits squarely in the outpatient category where payers have been tightening review criteria.

What’s Actually Driving the Increase?

Two forces are colliding: more procedures requiring authorization, and less clinical rigor behind the denials themselves. Nearly one in three physicians (32%) report that PA requests are often or always denied, according to the AMA’s 2025 survey. At the same time, only 24% of physicians say medical necessity denials are consistently reviewed by an appropriately qualified clinician, despite payer commitments to do exactly that.

That gap — high denial volume paired with thin clinical review — is why appeals often succeed when practices have the bandwidth to pursue them. The problem is most practices don’t.

What Does This Actually Cost an Orthopedic Practice?

Time, first — and time is money in a fee-for-service model. Physicians complete an average of 40 prior authorizations per week, per the AMA’s 2025 survey, with the 2024 survey putting the associated staff time at roughly 13 hours weekly. That’s a full administrative shift, every week, before a single claim is even submitted.

Then there’s the claims side. Kodiak Solutions’ Revenue Cycle Analytics, which tracks financial data from more than 1,850 hospitals and 250,000 physicians nationwide, found initial prior authorization and precertification denials on outpatient claims rose 16% from 2021 to 2023 — and inpatient claims rose 26% in the same window. Outpatient is where the bulk of orthopedic scheduling lives: imaging, injections, scoped procedures, and elective surgery.

MGMA’s 2026 Regulatory Burden Report adds another layer: 92% of surveyed medical group practices said they’ve had to hire or reassign staff specifically to keep up with prior authorization volume. That’s headcount spent chasing approvals instead of growing the practice.

What Can Practice Owners Actually Do About It?

Start by separating what you can control from what you can’t. You can’t control payer policy. You can control how tightly your intake, coding, and submission process is run before a request ever reaches a payer — because most denials on the front end are procedural, not clinical.

This is where credentialed human oversight matters more than software alone. Automated PA tools can flag missing fields; they can’t catch a payer’s shifting medical-necessity criteria or build the appeal that gets a legitimate case overturned. That takes a specialist who knows the payer, the CPT code, and the clinical documentation standard cold.

That’s the model behind Reviora Healthcare LLC’s approach: Expert-Led Technology, where credentialed specialists — not algorithms — drive every claims and authorization decision, with technology supporting their judgment rather than replacing it. Our orthopedic RCM work is governed by a Managed Outcomes Agreement (MOA) — a written, contractual performance agreement built around specific benchmarks — backed by a Benchmark Recovery Protocol that triggers a root-cause audit and corrective action plan if performance slips two months in a row. It’s accountability built into the contract, not a promise made in a sales call.

If your denial rate has crept up and you’re not sure whether it’s payer behavior or something fixable in your own workflow, that’s worth a real conversation. Book a free 30-minute consultation and we’ll walk through what your numbers are actually telling you.

Related reading: Orthopedic RCM Services | Claims Submission & Denial Management | The Reviora Guarantee

FAQ

Why are prior authorization denials going up for orthopedic practices? Payers have expanded which procedures require authorization while clinical review of denials has grown thinner — only 24% of physicians report denials are consistently reviewed by a qualified clinician, per AMA’s 2025 survey.

How much staff time does prior authorization actually take? Physicians complete an average of 40 PA requests weekly, with roughly 13 hours of associated staff time reported in AMA’s Prior Authorization Physician Survey data.

Are prior authorization denial rates the same across all insurers? No. KFF’s 2025 analysis of standard PA requests found denial rates ranging from 12% to 18% depending on the market segment (Medicare Advantage, Medicaid managed care, and ACA Marketplace).

What can a practice do to reduce denials without adding staff? Tightening front-end intake, coding accuracy, and documentation before submission catches most procedural denials before they happen — which is where a specialist-led RCM partner focuses first.

References

Why Behavioral Health Claims Get Denied More Than Almost Any Other Specialty

Posted on by Reviora Healthcare LLC in Uncategorized

Reviora Healthcare LLC | Guaranteed Revenue Partner

Every denied claim is a session you already delivered, a clinician you already paid, and revenue you have to fight to collect twice. If you run a behavioral health practice, you already know this fight happens more often than it should — and more often than it does for the orthopedic group down the street.

Is behavioral health actually denied more than other specialties?

The data says yes, structurally. MGMA’s 2023 DataDive Practice Operations dataset put the single-specialty aggregate first-submission denial rate at 8% — a rate that held steady from 2019. Behavioral health routinely runs above that baseline, and it’s not because your billing team is worse at their job.

It’s because behavioral health claims carry review requirements most specialties never touch: concurrent authorization for ongoing levels of care, session-count scrutiny past an arbitrary threshold, and “medical necessity” criteria that shift by payer. A clean claim in orthopedics stays clean. A clean claim in behavioral health can get re-reviewed mid-treatment. See how Reviora structures denial prevention for behavioral health practices →

Why does “medical necessity” cause so many denials here?

Because it’s the one determination payers apply more subjectively to behavioral health than to almost anything else. Physical medicine has objective markers — imaging, labs, wound measurements. Behavioral health has clinical judgment, and payers know that judgment is harder to defend claim-by-claim.

This is also where prior authorization does the most damage. The AMA’s 2024 Prior Authorization Physician Survey found physicians complete an average of 39 prior authorizations per week, consuming roughly 13 hours of physician and staff time — and nearly 1 in 3 physicians (31%) report those requests are often or always denied outright. Behavioral health, with its concurrent-review model, absorbs more of that cycle than most specialties because the authorization isn’t a one-time gate. It’s a recurring checkpoint your team has to clear every few sessions.

The cost of that checkpoint is measurable. CAQH’s 2024 Index Report found a manually processed prior authorization costs providers an average of $3.41 per transaction and takes about 24 minutes of staff time when handled by phone, fax, or email — compared to $0.05 and a fraction of the time when done electronically. For a behavioral health practice running concurrent reviews every few sessions across a full caseload, that gap compounds fast.

Doesn’t federal parity law prevent this?

It’s supposed to — and it doesn’t fully. The Mental Health Parity and Addiction Equity Act (MHPAEA) requires insurers to apply the same coverage standards to behavioral health as they do to medical and surgical care. In practice, a 2019 Milliman analysis of claims data covering more than 37 million people found the disparity in how often behavioral health inpatient care gets pushed out-of-network relative to medical/surgical care had grown 85% over the prior study period — evidence that payers still treat behavioral health differently on the ground, parity law notwithstanding.

MHPAEA restricts how payers can write their policies. It doesn’t stop a reviewer from disputing whether session 14 was still “medically necessary.” That gap is where your denials live.

Is this trend getting better or worse?

Worse, industry-wide. A March 2024 MGMA Stat poll found 60% of medical group leaders reported their claim denial rates increasing year over year — and only 11% had successfully brought their rates back down. Behavioral health practices, layering concurrent review and prior auth burden on top of that industry trend, are absorbing more than their share of that gap. See the full Reviora Guarantee framework →

What actually closes the gap?

Not appealing harder after the fact — fixing the workflow before the claim goes out. Practices that hold denial rates near the industry floor connect clinical documentation directly to coding before submission, track authorization windows proactively instead of reactively, and treat concurrent review as a scheduled task, not a surprise.

That’s the structural problem Reviora Healthcare is built to solve. Every Reviora client works under a Managed Outcomes Agreement — a written, contractual performance framework, not a marketing promise — with a Benchmark Recovery Protocol that activates automatically if performance on any core benchmark misses target two months in a row. Credentialed specialists lead every decision on your account; technology supports their work, it doesn’t replace their judgment. That’s what “Expert-Led Technology” means at Reviora. Learn more about our behavioral health billing and denial management process →

If your denial rate feels high and you’re not sure whether it’s normal for behavioral health or a fixable process gap, a 30-minute conversation will usually answer that question. Book a consultation →

FAQ

Why do behavioral health claims get denied more than medical claims?
Behavioral health relies on subjective medical necessity criteria and recurring concurrent review, while most other specialties are approved once and billed. That structural difference produces more denial opportunities per episode of care.

What’s a normal denial rate for a medical practice?
MGMA’s most recent DataDive benchmark puts the single-specialty aggregate first-submission denial rate at 8%. Behavioral health practices with strong documentation-to-coding workflows can approach that floor; those without it typically run well above it.

Does mental health parity law stop insurance companies from denying claims more often?
No. MHPAEA requires equal coverage standards, but it doesn’t prevent a payer from disputing medical necessity on a case-by-case basis — which is where most behavioral health denials originate.

How can I lower my practice’s behavioral health denial rate?
Start by auditing where clinical documentation and coding disconnect, and by tracking every authorization window proactively rather than reacting to denials after they happen. A revenue cycle partner with behavioral-health-specific processes can usually diagnose this in a short review.

Reference

  • MGMA DataDive Practice Operations (2023)
  • MGMA Stat poll (March 2024)
  • AMA 2024 Prior Authorization Physician Survey
  • CAQH 2024 Index Report
  • Milliman, Addiction and Mental Health vs. Physical Health
  • Widening Disparities in Network Use and Provider Reimbursement (2019)
  • U.S. Department of Labor, MHPAEA

Why Your Practice’s Claim Denial Rate Is Climbing in 2026 — And What the HFMA Benchmark Actually Means

Posted on by Reviora Healthcare LLC in Uncategorized

Reviora Healthcare LLC | Guaranteed Revenue Partner

If your billing team feels like they’re fighting more claims than they used to, they are. It’s not your coders getting sloppier — it’s the rules changing faster than most practices can track, and every denied claim is 30-60 days of cash flow you were counting on.

Here’s what’s actually happening, and where your numbers should sit.

Why Is My Denial Rate Going Up in 2026?

Three things are converging at once, and none of them are your billing team’s fault. Payers have tightened prior authorization enforcement, coding edit tables have changed, and adjudication software is flagging claims that would have sailed through two years ago.

This isn’t a perception problem. A recent MGMA Stat poll found that 60% of medical group leaders reported an increase in their practice’s claim denial rate — and only 11% had managed to bring their rate back down. That gap is the real story: most practices know denials are rising, but few have a structured process to reverse it.

Separately, MGMA’s benchmarking research on denials and appeals found that more than half of healthcare organizations now report denial rates exceeding 10% — double the top of HFMA’s acceptable range. Add in AMA’s 2024 Prior Authorization Physician Survey, which found physicians and staff spend an average of 13 hours per week per physician just processing authorization requests, and it’s clear: the administrative load behind every clean claim has gone up, even when nothing in your practice changed.

What Does the HFMA Benchmark Actually Say?

HFMA — the industry’s standard-setting body for revenue cycle metrics — considers a denial rate of 5% to 10% acceptable, with anything under 5% considered optimal performance. That’s the line, not a moving target and not a sales pitch. It’s the same MAP Keys framework hospitals, health systems, and physician groups are all measured against.

For context on where the industry actually sits: revenue cycle data from Kodiak Solutions, drawn from more than 2,100 hospitals and 300,000 physicians, shows the average initial denial rate climbed to 11.8% in 2024 — already above HFMA’s acceptable ceiling before 2025 and 2026 pressures compounded it further. If your practice is tracking anywhere close to that number, you’re not an outlier. You’re the norm right now, which is exactly the problem.

What Is This Actually Costing You?

Every denied claim doesn’t just delay payment — it consumes staff hours you’re already short on. Between prior authorization volume and appeals, front-office and billing staff are spending time on rework instead of revenue-generating work, and that labor cost rarely shows up on the P&L line labeled “denials.”

The slower cost is Days in AR creeping upward, month over month, until it’s normalized. A denial rate that sits at 10-12% doesn’t just cost the denied dollars — it drags down every other cash flow metric attached to it.

How Do You Get Back Under Benchmark?

his is where most practices try to solve a systems problem with more staff hours, and it doesn’t hold. The fix isn’t working denials harder after they happen — it’s closing the gaps that create them before a claim is ever submitted.

At Reviora, this is built into how we operate, not something we bolt on. Our team runs on Expert-Led Technology — credentialed billing and coding specialists lead every claim decision, using technology as a tool to catch what a payer will flag, not as a replacement for judgment. Every client engagement runs under a Managed Outcomes Agreement (MOA) — a written, contractual performance agreement built around defined benchmarks, including a denial rate target under 5%, matching HFMA’s optimal range rather than just its acceptable floor.

If a benchmark is missed two months in a row, our Benchmark Recovery Protocol (BRP) activates automatically — see What Happens If We Miss — a defined accountability process, not a vague promise to “look into it.”

If denial management specifically is your pain point, our Claims Submission & Denial Management page walks through how we structure that work day to day.

If your denial rate has been climbing and you’re not sure why, a second set of eyes on your claims data is usually the fastest way to find out. Book a free 30-minute consultation and we’ll walk through where your practice actually stands against benchmark. Not ready to talk yet? See what to expect from a first conversation before you reach out.

FAQ

What is a good claim denial rate for a medical practice? Per HFMA’s MAP Keys benchmark, 5-10% is considered acceptable, and under 5% is optimal. Above 10% signals a process gap worth investigating.

Why are claim denials increasing in 2026? Tighter prior authorization enforcement, updated payer coding edits, and more aggressive automated claims review are the main drivers, per MGMA and AMA survey data.

How do I lower my practice’s denial rate? Focus on the front end — eligibility verification, authorization matching, and clean coding before submission — since most denials are prevented, not appealed. A structured denial management process outperforms after-the-fact appeals.

Is a 10% denial rate bad? Yes — it’s above HFMA’s acceptable ceiling of 10% and roughly in line with the national average AHA reported for 2024 (11.8%), meaning a 10%+ rate puts a practice at or below where the broader industry already struggles.

Reference